Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6501 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6502 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 6503 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 6504 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 49 |
| 6505 | Apheresis | Allogeneic | Multiple Myeloma, Second Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 6506 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 6507 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 6508 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 6509 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 6510 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 6511 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 22 |
| 6512 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6513 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 6514 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6515 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 41 |
| 6516 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 6517 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 6518 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 44 |
| 6519 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2014 | Experimental Therapy | Poland | 6 |
| 6520 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 60,1 |
| 6521 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 24,1 |
| 6522 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 12,6 |
| 6523 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 8,3 |
| 6524 | Cord Tissue | Allogeneic – Unrelated | Birth Asphyxia; Retinopathy | Neurology | 2014 | Experimental Therapy | Poland | 11 months |
| 6525 | Cord Tissue | Allogeneic – Unrelated | Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth | Neurology | 2014 | Experimental Therapy | Poland | 2,1 |
| 6526 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 4,1 |
| 6527 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 15,1 |
| 6528 | Cord Tissue | Allogeneic – Unrelated | Muscular Dystrophy | Neurology | 2014 | Experimental Therapy | Poland | 6 |
| 6529 | Cord Tissue | Allogeneic – Unrelated | Neuropathy | Neurology | 2014 | Experimental Therapy | Poland | 23,6 |
| 6530 | Cord Blood | Allogeneic – Unrelated | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Spain | 15 |
| 6531 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Turkey | 8,8 |
| 6532 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 6533 | Cord Blood | Autologous | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Portugal | 6 |
| 6534 | Cord Blood | Allogeneic – Related | Beta Thalassemia | Hematology | 2014 | Standard Therapy | Germany | 6 |
| 6535 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Portugal | 4 |
| 6536 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | UK | 1 |
| 6537 | Cord Blood | Autologous | Hsv Encephalitis And Nmda Receptor Antibody Encephalitis | Neurology | 2014 | Experimental Therapy | UK | 2 |
| 6538 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2014 | Experimental Therapy | UK | 3 months |
| 6539 | Cord Blood | Allogeneic – Related | Leukemia | Hematology | 2014 | Standard Therapy | UK | 4 |
| 6540 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 11 |
| 6541 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 35 |
| 6542 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 73 |
| 6543 | Bone Marrow | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 6544 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6545 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 6546 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 6547 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 6548 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 6549 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 6550 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 29 |
| 6551 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 76 |
| 6552 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 48 |
| 6553 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 6554 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 6555 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 27 |
| 6556 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 6557 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
| 6558 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2014 | Standard Therapy | Germany | 67 |
| 6559 | Apheresis | Autologous | Bing–Neel Syndrome; Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 6560 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
| 6561 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2014 | Standard Therapy | Germany | 57 |
| 6562 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 6563 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 6564 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 50 |
| 6565 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 6566 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2014 | Standard Therapy | Germany | 24 |
| 6567 | Apheresis | Autologous | Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 6568 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 6569 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 6570 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 58 |
| 6571 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 6572 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 6573 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 6574 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 6575 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6576 | Apheresis | Autologous | Marginal Zone Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 6577 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2014 | Standard Therapy | Germany | 31 |
| 6578 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 6579 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 37 |
| 6580 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 19 |
| 6581 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 6582 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 6583 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6584 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 6585 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 66 |
| 6586 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6587 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 6588 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 6589 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6590 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 30 |
| 6591 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 6592 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 6593 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 77 |
| 6594 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 6595 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6596 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 6597 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 6598 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 6599 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 6600 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 49 |